Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems; Correction

---
identifier: "/us/fr/2018-05115"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2018-05115"
section_name: "Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems; Correction"
positive_law: false
currency: "2018-03-14"
last_updated: "2018-03-14"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2018-05115"
document_type: "rule"
publication_date: "2018-03-14"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 864"
fr_citation: "83 FR 11143"
fr_volume: 83
docket_ids:
  - "Docket No. FDA-2018-N-0399"
effective_date: "2018-03-14"
fr_action: "Final order; correction."
---


#  Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Final order; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a final order entitled “Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems” that appeared in the *Federal Register* of February 27, 2018. The document was published with the incorrect docket number. This document corrects that error.

**DATES:**

Effective March 14, 2018.

**FOR FURTHER INFORMATION CONTACT:**

Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg, 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of February 27, 2018 (83 FR 8355), in FR Doc. 2018-03924, on page 8355, the following correction is made:

1. On page 8355, in the third column, in the header of the document, the docket number is corrected to read “FDA-2018-N-0399”.

Dated: March 8, 2018.

Leslie Kux,

Associate Commissioner for Policy.